In the medical field, FDA approval is more meaningful than European approval. Hence some surgeons in Europe would wait for FDA approval before adopting, which is why the growth has not been significant for iTrack Advance in Europe. But since FDA approval, marketing outside of Europe has accelerated.
I'm expecting worldwide growth over the next several years. If growth hasn't materialised, then clearly the device is not up to scratch or the sales execution has been poor - if this is the case then I will take the hit on the share price.
- Forums
- ASX - By Stock
- EYE
- Nova Eye Medical (EYE) Discussion
Nova Eye Medical (EYE) Discussion, page-935
-
- There are more pages in this discussion • 2,253 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.91M |
Open | High | Low | Value | Volume |
24.0¢ | 24.5¢ | 24.0¢ | $110.1K | 458.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 432506 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 169560 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 432506 | 0.235 |
2 | 93400 | 0.230 |
3 | 75000 | 0.225 |
6 | 187721 | 0.220 |
3 | 188594 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 169560 | 3 |
0.250 | 3996 | 1 |
0.255 | 16768 | 2 |
0.260 | 50000 | 1 |
0.265 | 70000 | 3 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |